Delivery Order SPE2DB22D3102-SPE2DB25FL2YQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,029.95 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Chloraseptic Sore Throat Lozenges (18-count package). This competitively awarded, firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,119.84 for Chloraseptic sore throat lozenges (18-count). This firm fixed-price contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement relationship. The order will be performed in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $5,290.15 delivery order to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15 count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role in supplying...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,111.64, is for the supply of 4,567,926,337 units of Chloraseptic sore throat lozenges. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $314,790 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18-count packages of Chloraseptic sore throat lozenges. As part of DLA's medical supply chain support to the Department of Defense, this contract will provide sore throat relief medications to military treatment facilities from the contractor's distribution center in Conshohocken, Pennsylvania. Amerisourcebergen will fulfill the requirements as the prime contractor under this...
- This firm fixed-price delivery order, valued at $162, was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corporation for the supply of 18 count packages of Chloraseptic sore throat lozenges. Place of performance will be Amerisourcebergen's facilities in Conshohocken, Pennsylvania, with delivery required between July 10-11, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the U.S. Armed Forces through procurement...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Chloraseptic Max 15-10 mg Lozenges. The $2,054.66 firm-fixed-price contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a...
- The Defense Logistics Agency Troop Support Medical awarded a $4,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 15-count packages of 15 mg Chloraseptic lozenges. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania distribution facility. The single day order period is from August 15 to August 16, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will fulfill the order without the use of major...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Chloraseptic sore throat lozenges, with a ceiling value of $1,003.38 and a period of performance through May 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00...
- This contract award, valued at $2,241.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is a firm fixed price delivery order for the supply of pharmaceutical products, specifically Chloraseptic Max 15-10 mg lozenges, to support military treatment programs and facilities. The contract has an ultimate completion date of April 11, 2024. This delivery...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2YQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,744.20 to AmerisourceBergen Drug Corp for Chloraseptic Sore Throat Lozenges (18-count) on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single-line pharmaceutical product delivery under the contractor's existing federal contract vehicle with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a broad spectrum of medications, medical devices, and healthcare commodities to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations worldwide. The company's federal contracting portfolio demonstrates consistent capability in meeting open competition requirements for both routine medical supplies and specialized pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/11/25 |